August 6, 2024

Centerline’s IOPS Viewpoint Catheter Receives FDA Clearance

August 6, 2024—Centerline Biomedical, Inc. announced the expansion of its intraoperative positioning system (IOPS) portfolio with FDA 510(k) clearance of the IOPS Viewpoint catheter.

According to the company, the IOPS Viewpoint catheter is a low-profile 6-F catheter available in multiple tip shapes and lengths. It is designed for precision access to provide three-dimensional navigation feedback to clinicians.

Used in combination with the company’s algorithms of the IOPS software, Viewpoint catheters allow clinicians to clearly visualize endovascular tools in real time and reduce their dependency on fluoroscopy systems.

Centerline stated that the IOPS platform is designed to enhance visualization, minimize procedure times, and reduce total radiation exposure for the benefit of both patients and health care providers. IOPS has 510(k) clearance from the FDA for use in the descending aorta, advised the company.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

August 6, 2024

Centerline’s IOPS Viewpoint Catheter Receives FDA Clearance

Current Issue

Keep In Touch